Zydus Life Draws Focus After FDA Observations and Bernstein Upside View

Zydus Lifesciences shares are in focus after two company announcements concerning the US drug regulator. The USFDA issued five observations for the company's Moraiya manufacturing facility; Bernstein sees nearly 30% upside.